BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 15557170)

  • 21. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.
    Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L
    Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
    Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ
    J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells.
    Oberg HH; Wesch D; Kalyan S; Kabelitz D
    Front Immunol; 2019; 10():1690. PubMed ID: 31379875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alendronate liposomes for antitumor therapy: activation of γδ T cells and inhibition of tumor growth.
    Gutman D; Epstein-Barash H; Tsuriel M; Golomb G
    Adv Exp Med Biol; 2012; 733():165-79. PubMed ID: 22101722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
    Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
    J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
    Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
    J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.
    Casetti R; Perretta G; Taglioni A; Mattei M; Colizzi V; Dieli F; D'Offizi G; Malkovsky M; Poccia F
    J Immunol; 2005 Aug; 175(3):1593-8. PubMed ID: 16034098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit".
    Salot S; Bercegeay S; Dreno B; Saïagh S; Scaglione V; Bonnafous C; Sicard H
    J Immunol Methods; 2009 Aug; 347(1-2):12-8. PubMed ID: 19465023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human γδ T cell proliferation and effector functions by neutrophil serine proteases.
    Fazio J; Kalyan S; Wesch D; Kabelitz D
    Scand J Immunol; 2014 Dec; 80(6):381-9. PubMed ID: 25345993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset.
    Dalton JE; Pearson J; Scott P; Carding SR
    J Immunol; 2003 Dec; 171(12):6488-94. PubMed ID: 14662848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
    Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
    Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
    Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults.
    Fichtner AS; Bubke A; Rampoldi F; Wilharm A; Tan L; Steinbrück L; Schultze-Florey C; von Kaisenberg C; Prinz I; Herrmann T; Ravens S
    J Leukoc Biol; 2020 Jun; 107(6):1023-1032. PubMed ID: 32064671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model.
    Markle JG; Mortin-Toth S; Wong AS; Geng L; Hayday A; Danska JS
    J Immunol; 2013 Jun; 190(11):5392-401. PubMed ID: 23626013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
    Nedellec S; Sabourin C; Bonneville M; Scotet E
    J Immunol; 2010 Jul; 185(1):55-63. PubMed ID: 20511557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of lung gamma delta T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Dieli F; Ivanyi J; Marsh P; Williams A; Naylor I; Sireci G; Caccamo N; Di Sano C; Salerno A
    J Immunol; 2003 Jan; 170(1):463-9. PubMed ID: 12496432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
    Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
    J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.
    Dimova T; Brouwer M; Gosselin F; Tassignon J; Leo O; Donner C; Marchant A; Vermijlen D
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):E556-65. PubMed ID: 25617367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.